Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26e19c12ac350fc1c0c02bcf301685e6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c478f53813ed51016946ccc5dbd55e1 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-172 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6881 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6806 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6881 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6806 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-00 |
filingDate |
2001-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ad1bea18e9473a35512b5b774c1e5b1 |
publicationDate |
2002-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-0240711-A1 |
titleOfInvention |
Method for analysing a patient's predisposition to insulin-dependent diabetes, device and set of primers |
abstract |
The invention concerns a method for analysing a patient's genetic predisposition to insulin-dependent diabetes. The invention also concerns a device designed to implement said method and a set of amplifying primers adapted thereto. The method consists in placing a liquid sample containing at least one type of amplicons, derived from amplification of at least a polymorphic region of interest related to the searched disease, in the simultaneous presence of probes selected as follows: at least a probe specific of the patient's susceptibility to the disease; at least a probe specific of said patient's protection against said disease; and at least a probe specific of said patient's neutrality to said disease; and in revealing the hybridisation's produced. The invention is in particular applicable in the field of diagnosis. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9422598-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9771621-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9689041-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7553621-B2 |
priorityDate |
2000-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |